Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION - Co-Diagnostics, Inc. | codx_ex322.htm |
| EX-31.2 - CERTIFICATION - Co-Diagnostics, Inc. | codx_ex312.htm |
| EX-31.1 - CERTIFICATION - Co-Diagnostics, Inc. | codx_ex311.htm |
| 10-Q - FORM 10-Q - Co-Diagnostics, Inc. | codx_10q.htm |
EXHIBIT 32.1
Co-Diagnostics, Inc. & Subsidiaries
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S. C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of Co-Diagnostics, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2017, as filed with the Securities and Exchange Commission on the date hereof, Dwight H. Egan, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
| (1) | The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| (2) | The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
| |||
| Date: November 14, 2017 | By: | /s/ Dwight H. Egan | |
|
| Dwight H. Egan | ||
|
| Chief Executive Officer |